Equities analysts expect ICU Medical, Incorporated (NASDAQ:ICUI) to post $308.20 million in sales for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for ICU Medical’s earnings, with the highest sales estimate coming in at $313.00 million and the lowest estimate coming in at $303.40 million. ICU Medical posted sales of $360.46 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 14.5%. The firm is scheduled to issue its next earnings report on Thursday, August 8th.
On average, analysts expect that ICU Medical will report full year sales of $1.25 billion for the current year, with estimates ranging from $1.24 billion to $1.27 billion. For the next financial year, analysts anticipate that the company will post sales of $1.30 billion, with estimates ranging from $1.29 billion to $1.31 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of research firms that that provide coverage for ICU Medical.
ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Thursday, May 9th. The medical instruments supplier reported $2.35 EPS for the quarter, topping the Zacks’ consensus estimate of $1.96 by $0.39. ICU Medical had a return on equity of 13.70% and a net margin of 4.04%. The firm had revenue of $330.93 million during the quarter, compared to analyst estimates of $318.97 million. During the same period last year, the company earned $2.26 earnings per share. The business’s revenue for the quarter was down 11.0% on a year-over-year basis.
In related news, Director Robert S. Swinney sold 229 shares of the stock in a transaction on Friday, April 12th. The stock was sold at an average price of $231.43, for a total value of $52,997.47. Following the sale, the director now owns 18,076 shares in the company, valued at $4,183,328.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Kevin J. Mcgrody sold 7,344 shares of the stock in a transaction on Monday, June 10th. The stock was sold at an average price of $231.68, for a total value of $1,701,457.92. Following the completion of the sale, the insider now owns 7,574 shares in the company, valued at approximately $1,754,744.32. The disclosure for this sale can be found here. Insiders sold 12,921 shares of company stock worth $2,971,607 in the last quarter. 11.40% of the stock is currently owned by company insiders.
Several hedge funds have recently modified their holdings of ICUI. HighTower Advisors LLC grew its stake in shares of ICU Medical by 10.9% during the first quarter. HighTower Advisors LLC now owns 1,420 shares of the medical instruments supplier’s stock valued at $339,000 after buying an additional 139 shares during the last quarter. One Wealth Advisors LLC bought a new position in shares of ICU Medical during the first quarter valued at about $127,000. Goldman Sachs Group Inc. grew its stake in shares of ICU Medical by 8.6% during the first quarter. Goldman Sachs Group Inc. now owns 85,227 shares of the medical instruments supplier’s stock valued at $20,397,000 after buying an additional 6,758 shares during the last quarter. Oxford Asset Management LLP bought a new position in shares of ICU Medical during the first quarter valued at about $481,000. Finally, Utah Retirement Systems grew its stake in shares of ICU Medical by 2.9% during the first quarter. Utah Retirement Systems now owns 2,983 shares of the medical instruments supplier’s stock valued at $714,000 after buying an additional 83 shares during the last quarter. Institutional investors own 90.05% of the company’s stock.
Shares of ICU Medical stock traded up $2.38 during trading hours on Friday, reaching $241.71. The company had a trading volume of 140,104 shares, compared to its average volume of 148,704. ICU Medical has a one year low of $210.94 and a one year high of $321.70. The firm has a market capitalization of $4.93 billion, a P/E ratio of 31.35 and a beta of 0.72.
About ICU Medical
ICU Medical, Inc develops, manufactures, and sells medical devices used in vascular therapy, critical care, and oncology applications worldwide. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient's vein.
Further Reading: What are earnings reports?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.